Q1 2025 EPS Estimates for UnitedHealth Group Incorporated (NYSE:UNH) Lifted by Zacks Research

UnitedHealth Group Incorporated (NYSE:UNH) – Research analysts at Zacks Research upped their Q1 2025 earnings per share estimates for UnitedHealth Group in a research report issued to clients and investors on Tuesday, April 30th. Zacks Research analyst D. Chatterjee now anticipates that the healthcare conglomerate will post earnings per share of $7.21 for the quarter, up from their previous forecast of $7.01. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.60 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q2 2025 earnings at $7.35 EPS, Q3 2025 earnings at $8.29 EPS and Q4 2025 earnings at $8.23 EPS.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the company earned $6.26 EPS.

A number of other equities research analysts have also weighed in on the company. Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $492.45 on Friday. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market capitalization of $453.09 billion, a P/E ratio of 30.10, a P/E/G ratio of 1.40 and a beta of 0.55. The stock has a 50 day moving average price of $483.02 and a 200 day moving average price of $513.07.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Robbins Farley acquired a new stake in shares of UnitedHealth Group in the third quarter valued at $25,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at $31,000. Finally, NewSquare Capital LLC boosted its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.